一个单一机构对149例病例进行的临床预测研究

Xuejing Zheng1, Wence Wu1, Shengji Yu1

  • 1Department of Orthopedics, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

The American surgeon
|September 26, 2023
PubMed
概括

在中国患者中,Acral lentiginous melanoma (ALM) 往往是晚些时候诊断出来的. 较差结果的关键预后因素包括较短的病变持续时间,增加的Breslow厚度和淋巴结转移.